Supplementary File

Total Page:16

File Type:pdf, Size:1020Kb

Supplementary File Supplementary file COL1A2 FZD3 1 1 HPRD HPRD Humannet Humannet 0.8 PPIwu 0.8 PPIwu 0.6 0.6 0.4 0.4 Ratio of of indegree Ratio Ratio of Indegree 0.2 0.2 0 0 0 0.05 0.1 0.15 0.2 0 0.05 0.1 0.15 0.2 Frequency Frequency RBL1 SMARCA4 1 1 HPRD HPRD Humannet Humannet 0.8 PPIwu 0.8 PPIwu 0.6 0.6 0.4 0.4 Ratio of Indegree Ratio of Indegree Ratio 0.2 0.2 0 0 0 0.05 0.1 0.15 0.2 0 0.05 0.1 0.15 0.2 Frequency Frequency SRC TP53 1 1 HPRD Humannet 0.95 0.8 PPIwu 0.9 e 0.6 0.85 0.8 0.4 Ratio of Indegree of Ratio Ratio of Indegre 0.75 0.2 HPRD 0.7 Humannet PPIwu 0 0.65 0 0.05 0.1 0.15 0.2 0 0.05 0.1 0.15 0.2 Frequency Frequency VCAN 1 HPRD Humannet 0.8 PPIwu 0.6 0.4 Ratio of Indegree 0.2 0 0 0.05 0.1 0.15 0.2 Frequency Figure S1. Variation of indegree ratio with frequency cutoffs from 0 to 0.2 with a step 0.002 for driver genes common by three fitness cores in COAD. The indegree ratio is set to NULL if total degree of this genes is less than 5. BRAF CASR 1 1 0.8 0.8 0.6 0.6 0.4 0.4 Ratio of Indegree Ratio of Indegree of Ratio HPRD HPRD 0.2 0.2 Humannet Humannet PPIwu PPIwu 0 0 0 0.05 0.1 0.15 0.2 0 0.05 0.1 0.15 0.2 Frequency Frequency HDAC9 NRAS 1 1 0.8 0.8 0.6 0.6 0.4 0.4 HPRD HPRD Ratio of Indegree Ratio of Indegree 0.2 0.2 Humannet Humannet PPIwu PPIwu 0 0 0 0.05 0.1 0.15 0.2 0 0.05 0.1 0.15 0.2 Frequency Frequency NF1 CNTNAP2 1 1 0.9 0.8 0.8 0.6 0.7 0.4 HPRD HPRD Ratio of Indegree Ratio of Indegree 0.6 Humannet 0.2 Humannet PPIwu PPIwu 0.5 0 0 0.05 0.1 0.15 0.2 0 0.05 0.1 0.15 0.2 Frequency Frequency Figure S2. Variation of indegree ratio with frequency cutoffs from 0 to 0.2 with a step 0.002 for driver genes common by three fitness cores in primary melanoma. The indegree ratio is set to NULL if total degree of this genes is less than 5. (A) 1 1 1 0.9 0.9 0.9 0.8 0.8 0.8 0.7 0.7 0.7 0.6 0.6 0.6 0.5 0.5 Mean coverage ratio Mean ratioMean coverge Mean coverage ratio 0.4 0.5 0.4 0.3 0.4 0.3 0.2 0.1 0.2 0 100 200 300 400 500 600 700 800 900 1000 0 200 400 600 800 1000 0 100 200 300 400 500 600 700 800 900 1000 Sampling time Sampling time Sampling time (B) 1 1 1 0.9 0.9 0.9 0.8 0.8 0.8 0.7 0.7 0.7 0.6 0.6 0.6 0.5 0.5 0.5 0.4 0.4 Mean coverage rate Mean coverage ratio 0.4 Mean coverage ratio 0.3 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0 0.1 0 0 100 200 300 400 500 600 700 800 900 1000 0 100 200 300 400 500 600 700 800 900 1000 0 100 200 300 400 500 600 700 800 900 1000 Sampling time Sampling time Sampling time Figure S3. The convergence of sampling strategy in combinations of cases and background networks. (A) Mean coverage of driver genes in COAD with sampling times under HPRD (left), Humannet (middle) and PPIwu (right); (B) Mean coverage of driver genes in primary with sampling times under HPRD (left), Humannet (middle) and PPIwu (right). For a given driver gene and a case-background network combination, a universal set of driver genes covered by DIMs are generated by a 5000 times sampling procedure and DIM filtering procedure, and also subsets of DIM covered driver genes are generate by the same procedures with sampling time from 50 to 5000. Mean coverage is calculated for each sampling time by 100 repeats. The mean coverage is larger than 0.98 for almost all driver genes in each combination when sampling time get up to 1000, which implies the convergence of the sampling strategy employed in the flowchart. COAD COAD 4 5 HPRD HPRD Humannet Humannet 4 3 PPIwu PPIwu 3 2 2 1 Probability Density Probability Probability Density 1 0 0 0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1 Frequency Frequency Primary Melanoma Primary Melanoma 30 25 HPRD HPRD Humannet 25 Humannet PPIwu 20 PPIwu y 20 15 15 10 10 Probability Densit Probability Density Probability 5 5 0 0 0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1 Frequency Frequency Figure S4. Frequency distribution of fitness (left) and co-occurred (right) edges modeled by the kernel probability distribution with normal smoothing function. Results show significant differences of frequency distribution in different fitness networks. A COAD 1 1 P value (fitness) 0.9 P value (co-occur) 0.9 Overlap percent (fitness) Overlap percent (co-occur) 0.8 0.8 0.7 0.7 0.6 0.6 0.5 0.5 P value P 0.4 0.4 0.3 0.3 Percentage of overlapped edges 0.2 0.2 0.1 0.1 0 0 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 Percentage of edges with cutoff vs. all edges B Primary Melanoma 1 0.5 P value (Fitness) 0.9 P value (Co-occur) Overlap percent (Fitness) Overlap (Co-occur) 0.8 0.4 es 0.7 g 0.6 0.3 ed ed pp 0.5 P value P 0.4 0.2 overla of e g 0.3 Percenta 0.2 0.1 0.1 0 0 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 Percentage of edges with cutoff vs. all edges Figure S5. Percentage of the number of fitness and co-occurred edges common by fitness networks with frequency cutoffs and corresponding significance. Results indicate that consistent significances of fitness edges are obtained when percentage of edges in fitness networks larger than 0.23 and 0.28 for COAD and primary melanoma respectively, as well as 0.47 and 0.25 for co-occurred edges for COAD and primary melanoma respectively. Figure S6. Overlap of fitness cores identified under different background networks (HPRD, Humannet, PPIwu) in COAD (Figure A) and primary melanoma (Figure B). Significant overlaps are obtained in both of cases with p-value < 2.2E-16. Figure S7. A concise exhibition of functional relationships among top mutated driver genes for SKCM. Table S1. Fitness core obtained by combinations of cases and background networks cancer type Fitness core in FNs Fitness core in common BMP7, COL1A2, VCAN, LRP2, RBL1, SMARCA4, COAD (HPRD) SRC, TP53, USH2A, FZD3, TOMM34, NCOA6, PCDH17 BMP7, COL1A2, COL5A1, VCAN, DNAH5, PFDN4, COL1A2, VCAN, RBL1, COAD (Huannet) RBL1, SMARCA4, SRC, TP53, UBE2V1, FZD3, RAE1, SMARCA4, SRC, TP53, TCFL5, MXRA5 FZD3 COL1A2, COL5A1, VCAN, PFDN4, RBL1, SMARCA4, COAD (PPIwu) SRC, TP53, UBE2V1, FZD3, RAE1, TOMM34, MAPRE1, NEURL2, ASPM ACTN2, ZFHX3, BRAF, CASR, CDKN2A, CHGB, BRAF, CASR, NF1, NRAS, SKCM (HPRD) LYST, COL4A1, COL5A2, DSCAM, FLT1, GRM8, HDAC9, CNTNAP2 KDR, KEL, NF1, NID1, NRAS, ATXN1, SELE, CD163, MDC1, HDAC9, ADAM28, CNTNAP2, KCNQ5 ACTN2, ANK1, APOB, ZFHX3, BRAF, CASR, LYST, DSCAM, BPTF, GRIN2A, NF1, NRAS, PPP6C, PTEN, SKCM (Humannet) ATXN1, TTN, KMT2D, MDC1, HDAC9, CNTNAP2, CHD6 BRAF, CASR, CDKN2A, CLCN1, NF1, NRAS, HDAC9, SKCM (PPIwu) BCLAF1, CNTNAP2, PCDH18 Table S2 Absolute coverage of fitness cores FN num.all coverage.all num.core coverage.core num.core3 coverage.core3 COAD.hp 16 (440,271,0.8432) 13 (440,342,0.7773) 7 (440,307,0.6977) COAD.hu 25 (439,404,0.9203) 15 (439,337,0.7677) 7 (439,307,0.6993) COAD.wu 17 (439,334,0.7608) 15 (439,319,0.7267) 7 (439,307,0.6993) SKCM.hp 27 (350,315,0.9000) 25 (350,310,0.8857) 6 (350,298,0.8514) SKCM.hu 28 (357,334,0.9076) 21 (357,323,0.9048) 6 (357,298,0.8347) SKCM.wu 17 (348,316,0.9080) 10 (348,304,0.8736) 6 (348,298,0.8563) Table S3 Relative coverage of fitness cores FN num.all coverage.all num.core coverage.core num.core3 coverage.core3 COAD.hp 16 (440,371,0.8432) 13 (440,342,0.7773) 7 (440,307,0.6977) COAD.hu 25 (439,404,0.9203) 15 (439,337,0.7677) 7 (439,307,0.6993) COAD.wu 17 (438,333,0.7603) 15 (439,319,0.7267) 7 (439,307,0.6993) SKCM.hp 27 (150,115,0.7667) 25 (156,116,0.7436) 6 (167,123,0.7365) SKCM.hu 28 (169,136,0.8047) 21 (172,138,0.8023) 6 (195,144,0.7385) SKCM.wu 17 (128,99,0.7734) 10 (143,102,0.7133) 6 (138,99,0.7174) * FN: Fitness network.
Recommended publications
  • Identification of the Binding Partners for Hspb2 and Cryab Reveals
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 2013-12-12 Identification of the Binding arP tners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non- Redundant Roles for Small Heat Shock Proteins Kelsey Murphey Langston Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Microbiology Commons BYU ScholarsArchive Citation Langston, Kelsey Murphey, "Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins" (2013). Theses and Dissertations. 3822. https://scholarsarchive.byu.edu/etd/3822 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston A thesis submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Master of Science Julianne H. Grose, Chair William R. McCleary Brian Poole Department of Microbiology and Molecular Biology Brigham Young University December 2013 Copyright © 2013 Kelsey Langston All Rights Reserved ABSTRACT Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactors and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston Department of Microbiology and Molecular Biology, BYU Master of Science Small Heat Shock Proteins (sHSP) are molecular chaperones that play protective roles in cell survival and have been shown to possess chaperone activity.
    [Show full text]
  • ZMYND10 Functions in a Chaperone Relay During Axonemal Dynein Assembly
    bioRxiv preprint doi: https://doi.org/10.1101/233718; this version posted December 13, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 ZMYND10 functions in a chaperone relay during axonemal dynein assembly. 2 3 Girish R Mali1,9 , Patricia Yeyati1, Seiya Mizuno2, Margaret A Keighren1, Petra zur Lage3, Amaya 4 Garcia-Munoz4, Atsuko Shimada5, Hiroyuki Takeda5, Frank Edlich6, Satoru Takahashi2,7, Alex von 5 Kreigsheim4,8, Andrew Jarman3 and Pleasantine Mill1,*. 6 7 1. MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of 8 Edinburgh, Edinburgh, UK, EH4 2XU 9 2. Laboratory Animal Resource Centre, University of Tsukuba, Tsukuba, Japan, 305-8575 10 3. Centre for Integrative Physiology, University of Edinburgh, Edinburgh, UK, EH8 9XD 11 4. Systems Biology Ireland, University College Dublin, Dublin, Ireland 12 5. Department of Biological Sciences, University of Tokyo, Tokyo, Japan, 113-0033 13 6. Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany, 14 79104 15 7. Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, 16 Japan, 305-8575 17 8. Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University 18 of Edinburgh, Edinburgh, UK, EH4 2XU 19 9. Current address: MRC Laboratory of Molecular Biology, Cambridge, UK, CB2 0QH 20 * Corresponding author: [email protected] 21 22 23 24 25 26 27 28 29 30 31 1 bioRxiv preprint doi: https://doi.org/10.1101/233718; this version posted December 13, 2017.
    [Show full text]
  • Supplementary Materials Functional Characterization of Rare RAB12
    1 Supplementary materials Functional characterization of rare RAB12 variants and their role in musician’s and other dystonias Eva Hebert et al. Figure S1. Photograph of Individual L-10289 (mildly affected mother of the index patient from Family D) showing a 15-degree tilt of the trunk to the right as well as dystonic posturing of the right hand (involuntary flexion of the third to fifth finger and thumb and extension of the index finger). 2 Figure S2. TFRC colocalized with wildtype and mutant FLAG-RAB12. Immunofluorescent staining of fibroblasts expressing FLAG-RAB12 WT, p.Gly13Asp, or p.Ile196Val revealed predominant perinuclear localization of TFRC (red) which overlaps with the localization of FLAG-RAB12 (green) in all three cell lines (WT, p.Gly13Asp, p.Ile196Val). The nucleus was stained with DAPI (blue). Scale bar: 20µm. 3 Figure S3. Lysosomal degradation of the physiological dimeric TFRC was not affected by the RAB12 mutations. Western Blot analysis revealed the degradation of TFRC in patient fibroblasts with endogenous expression of RAB12 (a, b) in fibroblasts ectopically expressing FLAG-RAB12 (c, d), and in SH-SY5Y cells ectopically expressing FLAG-RAB12 (e, f). Cells were treated with Bafilomycin A1 for 24h. ß-actin served as loading control and for normalization. Bars in B, D, and F indicate means of three independent experiments ± SEM. ctrl control, WT wildtype 4 Figure S4. Relative LC3-II protein levels are marginally increased in SH-SY5Y cells overexpressing RAB12 Gly13Asp protein and p62 levels remained constant. a) Western Blot of proteins extracted from stably transfected SH-SY5Y cells. Expression of FLAG-tagged RAB12 WT equals the expression of mutated RAB12 proteins (Gly13Asp, I196Val) (lane 3, 5, 7).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Establishment of the Early Cilia Preassembly Protein Complex
    Establishment of the early cilia preassembly protein PNAS PLUS complex during motile ciliogenesis Amjad Horania,1, Alessandro Ustioneb, Tao Huangc, Amy L. Firthd, Jiehong Panc, Sean P. Gunstenc, Jeffrey A. Haspelc, David W. Pistonb, and Steven L. Brodyc aDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110; bDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110; cDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110; and dDepartment of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CA 90033 Edited by Kathryn V. Anderson, Sloan Kettering Institute, New York, NY, and approved December 27, 2017 (received for review September 9, 2017) Motile cilia are characterized by dynein motor units, which preas- function of these proteins is unknown; however, missing dynein semble in the cytoplasm before trafficking into the cilia. Proteins motor complexes in the cilia of mutants and cytoplasmic locali- required for dynein preassembly were discovered by finding human zation (or absence in the cilia proteome) suggest a role in the mutations that result in absent ciliary motors, but little is known preassembly of dynein motor complexes. Studies in C. reinhardtii about their expression, function, or interactions. By monitoring show motor components in the cell body before transport to ciliogenesis in primary airway epithelial cells and MCIDAS-regulated flagella (22–25). However, the expression, interactions, and induced pluripotent stem cells, we uncovered two phases of expres- functions of preassembly proteins, as well as the steps required sion of preassembly proteins. An early phase, composed of HEATR2, for preassembly, are undefined.
    [Show full text]
  • De Novo, Systemic, Deleterious Amino Acid Substitutions Are Common in Large Cytoskeleton‑Related Protein Coding Regions
    BIOMEDICAL REPORTS 6: 211-216, 2017 De novo, systemic, deleterious amino acid substitutions are common in large cytoskeleton‑related protein coding regions REBECCA J. STOLL1, GRACE R. THOMPSON1, MOHAMMAD D. SAMY1 and GEORGE BLANCK1,2 1Department of Molecular Medicine, Morsani College of Medicine, University of South Florida; 2Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA Received June 13, 2016; Accepted October 31, 2016 DOI: 10.3892/br.2016.826 Abstract. Human mutagenesis is largely random, thus large Introduction coding regions, simply on the basis of probability, represent relatively large mutagenesis targets. Thus, we considered Genetic damage is largely random and therefore tends to the possibility that large cytoskeletal-protein related coding affect the larger, functional regions of the human genome regions (CPCRs), including extra-cellular matrix (ECM) more frequently than the smaller regions (1). For example, coding regions, would have systemic nucleotide variants that a systematic study has revealed that cancer fusion genes, on are not present in common SNP databases. Presumably, such average, are statistically, significantly larger than other human variants arose recently in development or in recent, preceding genes (2,3). The large introns of potential cancer fusion genes generations. Using matched breast cancer and blood-derived presumably allow for many different productive recombina- normal datasets from the cancer genome atlas, CPCR single tion opportunities, i.e., many recombinations that would allow nucleotide variants (SNVs) not present in the All SNPs(142) for exon juxtaposition and the generation of hybrid proteins. or 1000 Genomes databases were identified. Using the Protein Smaller cancer fusion genes tend to be associated with the rare Variation Effect Analyzer internet-based tool, it was discov- types of cancer, for example EWS RNA binding protein 1 in ered that apparent, systemic mutations (not shared among Ewing's sarcoma.
    [Show full text]
  • Next Generation Massively Parallel Sequencing of Targeted
    ARTICLE Next generation massively parallel sequencing of targeted exomes to identify genetic mutations in primary ciliary dyskinesia: Implications for application to clinical testing Jonathan S. Berg, MD, PhD1,2, James P. Evans, MD, PhD1,2, Margaret W. Leigh, MD3, Heymut Omran, MD4, Chris Bizon, PhD5, Ketan Mane, PhD5, Michael R. Knowles, MD2, Karen E. Weck, MD1,6, and Maimoona A. Zariwala, PhD6 Purpose: Advances in genetic sequencing technology have the potential rimary ciliary dyskinesia (PCD) is an autosomal recessive to enhance testing for genes associated with genetically heterogeneous Pdisorder involving abnormalities of motile cilia, resulting in clinical syndromes, such as primary ciliary dyskinesia. The objective of a range of manifestations including situs inversus, neonatal this study was to investigate the performance characteristics of exon- respiratory distress at full-term birth, recurrent otitis media, capture technology coupled with massively parallel sequencing for chronic sinusitis, chronic bronchitis that may result in bronchi- 1–3 clinical diagnostic evaluation. Methods: We performed a pilot study of ectasis, and male infertility. The disorder is genetically het- four individuals with a variety of previously identified primary ciliary erogeneous, rendering molecular diagnosis challenging given dyskinesia mutations. We designed a custom array (NimbleGen) to that mutations in nine different genes (DNAH5, DNAH11, capture 2089 exons from 79 genes associated with primary ciliary DNAI1, DNAI2, KTU, LRRC50, RSPH9, RSPH4A, and TX- dyskinesia or ciliary function and sequenced the enriched material using NDC3) account for only approximately 1/3 of PCD cases.4 the GS FLX Titanium (Roche 454) platform. Bioinformatics analysis DNAH5 and DNAI1 account for the majority of known muta- was performed in a blinded fashion in an attempt to detect the previ- tions, and the other genes each account for a small number of ously identified mutations and validate the process.
    [Show full text]
  • Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells
    molecules Article Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells Michele Costanzo 1,2 , Marco Fiocchetti 3 , Paolo Ascenzi 3, Maria Marino 3 , Marianna Caterino 1,2,* and Margherita Ruoppolo 1,2,* 1 Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples Federico II, 80131 Naples, Italy; [email protected] 2 CEINGE—Biotecnologie Avanzate S.C.Ar.L., 80145 Naples, Italy 3 Department of Science, University Roma Tre, 00146 Rome, Italy; marco.fi[email protected] (M.F.); [email protected] (P.A.); [email protected] (M.M.) * Correspondence: [email protected] (M.C.); [email protected] (M.R.) Abstract: Neuroglobin (NGB) is a myoglobin-like monomeric globin that is involved in several processes, displaying a pivotal redox-dependent protective role in neuronal and extra-neuronal cells. NGB remarkably exerts its function upon upregulation by NGB inducers, such as 17β-estradiol (E2) and H2O2. However, the molecular bases of NGB’s functions remain undefined, mainly in non- neuronal cancer cells. Human MCF-7 breast cancer cells with a knocked-out (KO) NGB gene obtained using CRISPR/Cas9 technology were analyzed using shotgun label-free quantitative proteomics in comparison with control cells. The differential proteomics experiments were also performed after treatment with E2, H2O2, and E2 + H2O2. All the runs acquired using liquid chromatography–tandem mass spectrometry were elaborated within the same MaxQuant analysis, leading to the quantification Citation: Costanzo, M.; Fiocchetti, of 1872 proteins in the global proteomic dataset. Then, a differentially regulated protein dataset was M.; Ascenzi, P.; Marino, M.; Caterino, M.; Ruoppolo, M.
    [Show full text]
  • Supplementary Table S1. Correlation Between the Mutant P53-Interacting Partners and PTTG3P, PTTG1 and PTTG2, Based on Data from Starbase V3.0 Database
    Supplementary Table S1. Correlation between the mutant p53-interacting partners and PTTG3P, PTTG1 and PTTG2, based on data from StarBase v3.0 database. PTTG3P PTTG1 PTTG2 Gene ID Coefficient-R p-value Coefficient-R p-value Coefficient-R p-value NF-YA ENSG00000001167 −0.077 8.59e-2 −0.210 2.09e-6 −0.122 6.23e-3 NF-YB ENSG00000120837 0.176 7.12e-5 0.227 2.82e-7 0.094 3.59e-2 NF-YC ENSG00000066136 0.124 5.45e-3 0.124 5.40e-3 0.051 2.51e-1 Sp1 ENSG00000185591 −0.014 7.50e-1 −0.201 5.82e-6 −0.072 1.07e-1 Ets-1 ENSG00000134954 −0.096 3.14e-2 −0.257 4.83e-9 0.034 4.46e-1 VDR ENSG00000111424 −0.091 4.10e-2 −0.216 1.03e-6 0.014 7.48e-1 SREBP-2 ENSG00000198911 −0.064 1.53e-1 −0.147 9.27e-4 −0.073 1.01e-1 TopBP1 ENSG00000163781 0.067 1.36e-1 0.051 2.57e-1 −0.020 6.57e-1 Pin1 ENSG00000127445 0.250 1.40e-8 0.571 9.56e-45 0.187 2.52e-5 MRE11 ENSG00000020922 0.063 1.56e-1 −0.007 8.81e-1 −0.024 5.93e-1 PML ENSG00000140464 0.072 1.05e-1 0.217 9.36e-7 0.166 1.85e-4 p63 ENSG00000073282 −0.120 7.04e-3 −0.283 1.08e-10 −0.198 7.71e-6 p73 ENSG00000078900 0.104 2.03e-2 0.258 4.67e-9 0.097 3.02e-2 Supplementary Table S2.
    [Show full text]
  • Antibody List 2014
    Antibody List 2014 Office of Technology Transfer, DKFZ Terms and Conditions Terms and conditions for licensing DKFZ’s antibodies are available upon request. Disclaimer This antibody list is neither exhaustive nor qualifies as a commercial catalogue. DKFZ has prepared the contents of this list to the best of its knowledge and confirms to the best of its knowledge that the listed antibodies are created at or in cooperation with DKFZ. DKFZ does not warrant that any listed antibody is available. Moreover DKFZ does not warrant that any listed antibody and / or the use thereof is not protected by any third party rights. Contact: Office of Technology Transfer (T010) Deutsches Krebsforschungszentrum (DKFZ) German Cancer Research Center Im Neuenheimer Feld 280 69120 Heidelberg Germany E-mail: [email protected] Index MMP9 AATF Hexa-His MPO ABCB5 HIP128 Myo II AID HIP150 NET1 AGO1 HIPK-2 Nephrin AuroraC HIPPI NF1 APC Histone H1.0 NM-1 (NMy1) BPAG Histone H1.2 NMUR-2 BPV1 L1 Histone H1.3 NO-52 BPV1 E7 Histone H1.4 NO-66 BTG2 HLA-DM NO-145 CCDC103 HLA-DO NPHP1 CCR4 HLA-DP NPHP3 CCR8 HLA-DQ NPHP4 CCR9 HLA-DR NPM CCR10 HPV11 L1 Nup88 CD3 HPV11 E2 Nus/S-tag CD19 HPV16 L1 OCAB CD22 HPV16 L2 ODA7 CD23 HPV16 E5 PACS-1 CD37 HPV16 E6 PACT CD53 HPV16 E7 p16 CD56 HPV18 E6 p27KIP CD71 HPV18 E7 p53 CD171 (L1CAM) HPV20 E6 Pick CEACAM1 HPV20 E7 PKD1 Cep170 HPV27 E6 PIF Densin HPV27 E7 Plasminogen acitvator (PA) DLL4 HSC70 Podocin DNAH3 HSP70 PSA DNAH5 Jade1 PSMA DNAH8 JAM4 PTEN DNAH11 Ki67 RFP2 DNAse1 KTU RGS7 DSC2 LaminA RIP140 EGFR LaminB1
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Genome-Wide Identification, Characterization and Expression
    G C A T T A C G G C A T genes Article Genome-Wide Identification, Characterization and Expression Profiling of myosin Family Genes in Sebastes schlegelii Chaofan Jin 1, Mengya Wang 1,2, Weihao Song 1 , Xiangfu Kong 1, Fengyan Zhang 1, Quanqi Zhang 1,2,3 and Yan He 1,2,* 1 MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China; [email protected] (C.J.); [email protected] (M.W.); [email protected] (W.S.); [email protected] (X.K.); [email protected] (F.Z.); [email protected] (Q.Z.) 2 Laboratory of Tropical Marine Germplasm Resources and Breeding Engineering, Sanya Oceanographic Institution, Ocean University of China, Sanya 572000, China 3 Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266003, China * Correspondence: [email protected]; Tel.: +86-0532-82031986 Abstract: Myosins are important eukaryotic motor proteins that bind actin and utilize the energy of ATP hydrolysis to perform a broad range of functions such as muscle contraction, cell migration, cytokinesis, and intracellular trafficking. However, the characterization and function of myosin is poorly studied in teleost fish. In this study, we identified 60 myosin family genes in a marine teleost, black rockfish (Sebastes schlegelii), and further characterized their expression patterns. myosin showed divergent expression patterns in adult tissues, indicating they are involved in different types and Citation: Jin, C.; Wang, M.; Song, W.; compositions of muscle fibers. Among 12 subfamilies, S. schlegelii myo2 subfamily was significantly Kong, X.; Zhang, F.; Zhang, Q.; He, Y.
    [Show full text]